Lipid-based nanoparticles for photosensitive drug delivery systems

다국어 초록 (Multilingual Abstract)

Background Numerous drug delivery strategies have been studied, but many hurdles exist in drug delivery rates to the target site. Recently, researchers have attempted to remotely control the in vivo behavior of drugs with light to overcome the shortcomings of conventional drug delivery systems. Photodynamic and photothermal systems are representative strategies wherein a photosensitive material is activated in response to a specific wavelength of light.
Area covered Photosensitive materials generally exhibit poor solubility and low biocompatibility. Additionally, their low photostability negatively affects delivery performance. A formulation of lipid-based nanoparticles containing photosensitive substances can help achieve photosensitive drug delivery with improved biocompatibility. The lipid bilayer structure, which can be assembled and disassembled by modulating the surrounding conditions (temperature, pH, etc.), can also be crucial for controlled release of drugs.
Expert opinion To the best of our knowledge, translation research on photoresponsive nanoparticles is scarce. However, as various drugs based on lipid nanoparticles have been clinically approved, the development potential of the lipid-based photoresponsive nanoparticles seems high. Thus, the identification of valid indications and development of optimum medical devices will increase the interest in photoresponsive material-based nanoparticles.

참고문헌 (Reference)

1 Schoenmaker L, "mRNA-lipid nanoparticle COVID-19 vaccines : structure and stability" 601 : 120586-, 2021

2 Jana NR, "Wet chemical synthesis of high aspect ratio cylindrical gold nanorods" 105 : 4065-4067, 2001

3 Ali S, "Wavelength dependent photo-cytotoxicity to ovarian carcinoma cells using temoporfin loaded tetraether liposomes as efficient drug delivery system" 150 : 50-65, 2020

4 Luo D, "Vessel-targeted chemophototherapy with cationic porphyrin-phospholipid liposomes" 16 : 2452-2461, 2017

5 Li Y, "The comparative effect of wrapping solid gold nanoparticles and hollow gold nanoparticles with doxorubicin-loaded thermosensitive liposomes for cancer thermo-chemotherapy" 10 : 8628-8641, 2018

6 Zhao Y, "Temperature-sensitive lipid-coated carbon nanotubes for synergistic photothermal therapy and gene therapy" 15 : 6517-6529, 2021

7 Shim G, "Tannic acidfunctionalized boron nitride nanosheets for theranostics" 327 : 616-626, 2020

8 Carter KA, "Sphingomyelin liposomes containing porphyrin-phospholipid for irinotecan chemophototherapy" 6 : 2329-2336, 2016

9 Kharlamov AN, "Silica–gold nanoparticles for atheroprotective management of plaques : results of the NANOM-FIM trial" 7 : 8003-8015, 2015

10 Liu Y, "Self-assembly of stimuli-responsive Au–Pd bimetallic nanoflowers based on betulinic acid liposomes for synergistic chemo-photothermal cancer therapy" 4 : 2911-2921, 2018

11 Miao W, "Safety and tumor tissue accumulation of pegylated graphene oxide nanosheets for co-delivery of anticancer drug and photosensitizer" 34 : 3402-3410, 2013

12 Tagami T, "Recent trends in clinical trials related to carrier-based drugs" 106 : 2219-2226, 2017

13 Liu Y, "Preparation, microstructure and function of liposome with light responsive switch" 178 : 238-244, 2019

14 Lovell JF, "Porphysome nanovesicles generated by porphyrin bilayers for use as multimodal biophotonic contrast agents" 10 : 324-332, 2011

15 Kharlamov AN, "Plasmonic photothermal therapy of atherosclerosis with nanoparticles : long-term outcomes and safety in NANOM-FIM trial" 13 : 345-363, 2017

16 Harewood GC, "Pilot study to assess patient outcomes following endoscopic application of photodynamic therapy for advanced cholangiocarcinoma" 20 : 415-420, 2005

17 Viitala L, "Photothermally triggered lipid bilayer phase transition and drug release from gold nanorod and indocyanine green encapsulated liposomes" 32 : 4554-4563, 2016

18 Le Q-V, "Photosensitizer-free phototherapy with peptide micelle nanoadjuvants for cancer vaccine against metastasis of melanoma" 2 : 2000288-, 2021

19 Brackett CM, "Photodynamic therapy enhancement of anti-tumor immunity" 10 : 649-652, 2011

20 Uda RM, "Photo-triggered release from liposomes without membrane solubilization, based on binding to poly(vinyl alcohol)carrying a malachite green moiety" 146 : 716-721, 2016

21 Shim G, "Noncovalent tethering of nucleic acid aptamer on DNA nanostructure for targeted photo/chemo/gene therapies" 24 : 102053-, 2020

22 Wiraja C, "Near-infrared light-sensitive liposomes for enhanced plasmid DNA transfection" 1 : 357-364, 2016

23 Pacheco TJA, "Nano COVID-19 vaccines : the firsts RNA lipid nanoparticle vaccines being approved from history-review" 9 : e20191211123-, 2020

24 Dai Y, "Multifunctional thermosensitive liposomes based on natural phase-change material : Near-infrared light-triggered drug release and multimodal imaging-guided cancer combination therapy" 11 : 10540-10553, 2019

25 Yang H, "Molecular engineering of antibodies for site-specific conjugation to lipid polydopamine hybrid nanoparticles" 10 : 2212-2226, 2020

26 Boccalini G, "Methylene blue-containing liposomes as new photodynamic anti-bacterial agents" 5 : 2788-2797, 2017

27 Wu Y, "Melanin-loaded CpG DNA hydrogel for modulation of tumor immune microenvironment" 330 : 540-553, 2021

28 Arslan H, "Measurement of the penetration depth in biological tissue for different optical powers" 22 : 1095-1100, 2018

29 Al-Jamal WT, "Liposomes : From a clinically established drug delivery system to a nanoparticle platform for theranostic nanomedicine" 44 : 1094-1104, 2011

30 Bulbake U, "Liposomal formulations in clinical use : An updated review" 9 : 12-, 2017

31 Ribovski L, "Lightinduced molecular rotation triggers on-demand release from liposomes" 56 : 8774-8777, 2020

32 Zhang K, "Light-triggered theranostic liposomes for tumor diagnosis and combined photodynamic and hypoxia-activated prodrug therapy" 185 : 301-309, 2018

33 Appidi T, "Light-triggered selective ROS-dependent autophagy by bioactive nanoliposomes for efficient cancer theranostics" 12 : 2028-2039, 2020

34 Chen W, "Light-triggerable liposomes for enhanced endolysosomal escape and gene silencing in PC12 cells" 7 : 366-377, 2017

35 Shim G, "Light-switchable systems for remotely controlled drug delivery" 267 : 67-79, 2017

36 Yang Y, "Light-activatable liposomes for repetitive on-demand drug release and immunopotentiation in hypoxic tumor therapy" 265 : 120456-, 2021

37 Hashemi M, "Layer-by-layer assembly of graphene oxide on thermosensitive liposomes for photo-chemotherapy" 65 : 376-392, 2018

38 Mang TS, "Lasers and light sources for PDT : past, present and future" 1 : 43-48, 2004

39 Feng L, "Iridium nanocrystals encapsulated liposomes as near-infrared light controllable nanozymes for enhanced cancer radiotherapy" 181 : 81-91, 2018

40 Swenson CE, "Increased duration of heating boosts local drug deposition during radiofrequency ablation in combination with thermally sensitive liposomes(ThermoDox)in a porcine model" 10 : e0139752-, 2015

41 Le QV, "In situ nanoadjuvant-assembled tumor vaccine for preventing long-term recurrence" 13 : 7442-7462, 2019

42 Tang X, "Hypoxia-activated ROS burst liposomes boosted by local mild hyperthermia for photo/chemodynamic therapy" 328 : 100-111, 2020

43 Salmivuori M, "Hexyl aminolevulinate, 5-aminolevulinic acid nanoemulsion and methyl aminolevulinate in photodynamic therapy of non-aggressive basal cell carcinomas : a non-sponsored, randomized, prospective and double-blinded trial" 34 : 2781-2788, 2020

44 Iyer AK, "Exploiting the enhanced permeability and retention effect for tumor targeting" 11 : 812-818, 2006

45 Shah SA, "Doxorubicin-loaded photosensitive magnetic liposomes for multi-modal cancer therapy" 148 : 157-164, 2016

46 Hernández-Ainsa S, "Controlling the reversible assembly of liposomes through a multistimuli responsive anchored DNA" 16 : 4462-4466, 2016

47 Luo L, "Combined near infrared photothermal therapy and chemotherapy using gold nanoshells coated liposomes to enhance antitumor effect" 12 : 4103-4112, 2016

48 Lyon PC, "Clinical trial protocol for TARDOX : a phase I study to investigate the feasibility of targeted release of lyso-thermosensitive liposomal doxorubicin(ThermoDox®)using focused ultrasound in patients with liver tumours" 5 : 28-, 2017

49 Allison RR, "Clinical PD/PDT in North America : a historical review" 1 : 263-277, 2004

50 Miao W, "Cholesteryl hyaluronic acid-coated, reduced graphene oxide nanosheets for anti-cancer drug delivery" 34 : 9638-9647, 2013

51 Ko S, "Chemokine-mimetic plerixafor derivative for tumor-specific delivery of nanomaterials" 11 : 2159-2172, 2018

52 Moriwaki SI, "Analysis of photosensitivity in Japanese cancer-bearing patients receiving photodynamic therapy with porfimer sodium(PhotofrinTM)" 17 : 241-243, 2001

53 Shi J, "A nanoliposomebased photoactivable drug delivery system for enhanced cancer therapy and overcoming treatment resistance" 12 : 8257-8275, 2017